A detailed history of Bka Wealth Consulting, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bka Wealth Consulting, Inc. holds 1,251 shares of ABBV stock, worth $219,650. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,251
Previous 1,249 0.16%
Holding current value
$219,650
Previous $214,000 15.42%
% of portfolio
0.27%
Previous 0.26%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.16%
1,251 $247,000
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.08%
1,249 $214,000
Q1 2024

Apr 09, 2024

BUY
$159.82 - $182.1 $199,455 - $227,260
1,248 New
1,248 $227,000
Q1 2023

May 30, 2023

SELL
$144.61 - $166.54 $191,174 - $220,165
-1,322 Reduced 50.92%
1,274 $203,000
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $196,091 - $225,828
1,356 Added 109.35%
2,596 $413,000
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $171,504 - $205,678
1,240 New
1,240 $200,000
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $170,098 - $216,250
-1,236 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $163,127 - $202,395
1,236 New
1,236 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bka Wealth Consulting, Inc. Portfolio

Follow Bka Wealth Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bka Wealth Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bka Wealth Consulting, Inc. with notifications on news.